Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UBT (Umbria Bioengineering Technologies) is an Italian medical technology company specializing in the development of innovative medical imaging devices based on microwave technology. The company's flagship product, MammoWave, is a radiation-free breast imaging system designed for cancer screening that operates without breast compression, making it a safer and more comfortable alternative to traditional mammography. Beyond oncology, UBT is expanding its microwave imaging platform to neurology with BrainWave, a portable device intended for the rapid detection and classification of strokes and brain lesions. By utilizing non-ionizing electromagnetic fields, UBT aims to provide accessible, cost-effective, and safe diagnostic solutions for global healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UBT.